Plasma and synovial fluid endothelin-1 and nitric oxide concentrations in horses with and without joint disease.

This study explores the levels of endothelin-1 (ET-1) and nitric oxide (NO) in the blood and joint fluid of horses with and without joint disorders. It reveals that horses with joint disease, particularly sepsis, displayed significantly higher concentrations of ET-1 in their joint fluid, suggesting a role in the disease process.

Objective and Methodology

The objective of the study was to compare the levels of two compounds – endothelin-1 (ET-1) and nitric oxide (NO) – in the plasma (blood) and synovial fluid (joint fluid) of normal horses and those suffering from joint diseases. The focus was on understanding if these compounds could be implicated in joint diseases in horses.

A total of 36 horses with joint disease and 15 without were included in the study. Horses with joint diseases were further categorized into three groups based on their specific condition – synovitis, degenerative joint disease (DJD), or joint sepsis. This categorization was made based on clinical and radiographic examination, alongside analysis of synovial fluid.

Samples for the study were collected from the jugular vein and the vein of the limb with the affected joint. Synovial fluid samples were also collected from the affected joint.

Results

• The plasma levels of ET-1 and NO were similar for both healthy horses and those with joint diseases. This implies that the presence of joint disease does not significantly affect the concentration of these compounds in the blood.
• However, there were marked differences when it came to ET-1 concentrations in the synovial fluid of different groups. The joint sepsis group had significantly higher levels of ET-1 compared to other groups, followed by the DJD group, the synovitis group and lastly the unaffected (healthy) group.
• There was no significant difference between NO concentration in synovial fluid across various groups, suggesting it may not be substantially involved in these joint diseases.

Conclusion

From the results, it was concluded that ET-1 is produced locally in the joints of horses with different types of joint diseases. The concentration of ET-1 in the synovial fluid varied depending on the specific joint disease, and was particularly high in horses suffering from joint sepsis. Thus, ET-1 seems to play a role in joint diseases in horses, and may contribute to the pathophysiology of such conditions. The insights from this study can be used for further research into the mechanisms of joint disease in horses and potential therapeutic interventions.